Immunology therapies supporting the management of autoimmune conditions.
Our Portfolio
Products in this therapeutic area
1 product manufactured or supplied by Sudair Pharma. Product information is intended for healthcare professionals; please refer to the approved prescribing information.
Ruxaar
Ruxaar® Indication: Treatment of rheumatoid arthritis and severe, uncontrolled psoriasis. Strength: 2.5 mg Dosage Form: Tablets Active Ingredient: Methotrexate
Manufactured to international standards
Every product in this portfolio is made under cGMP, in facilities aligned to SFDA, PIC/S, ISO and WHO expectations.
Enquiries
Looking for product information?
Our medical and regulatory teams can support healthcare professionals with product enquiries and prescribing information.